Bioneer Develops Ebola MDx Kit in Partnership with Nigerian Biotech Agency | GenomeWeb

NEW YORK (GenomeWeb) — South Korean molecular diagnostics firm Bioneer announced on Wednesday the availability of a molecular test kit for the Ebola virus that it has developed in collaboration with the Nigerian National Biotechnology Development Agency (NABDA).

Specifically, the company's AccuPower EBOV real-time RT-PCR kit is optimized for detection of the Zaire subtype of the Ebola virus associated with recent outbreaks in Africa. Bioneer has worked with NABDA since April to develop means to rapidly detect this subtype.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: experts say race is not a sufficient proxy for studying human genetic diversity and more.

Technology Review writes that CRISPR/Cas9 gene editing firm Editas' success may hinge on a patent case.

Researchers unearthed a bioinformatics error in the Science paper reporting the first ancient African genome, and the authors are seeking an erratum.

A boy's cystic fibrosis carrier status was revealed by a teacher to the parents of children with CF who then sought the boy's transfer to another school, leading to a lawsuit.